查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球肠内餵养配方市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342978

全球肠内餵养配方市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Enteral Feeding Formulas Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 235 Pages | 商品交期: 最快1-2个工作天内

价格

全球肠内餵养配方奶粉市场需求预计将从 2022 年的 96.2 亿美元增至 2030 年的近 187.9 亿美元，2023-2030 年研究期间复合年增长率为 7.72%。

肠内餵养配方食品也称为管饲配方食品，用于治疗癌症、进食障碍、慢性病、危及生命的伤害以及中风或发作等疾病。术语肠内餵养描述了通过胃肠道摄入食物的过程。胃、食道、肠和口腔构成胃肠道。通过管子摄取的营养直接进入胃和小肠。这种形式的餵养方法是作为补充。这种餵养方法使患者能够获得保持胃肠道活跃的营养。

市场动态：

肠内餵养配方奶粉市场的强劲增长是由于癌症、痴呆、中风、多发性硬化症、慢性阻塞性肺病（COPD）、肝臟疾病和其他慢性疾病的患病率不断上升而推动的。早产的增加是促进市场增长的另一个主要因素。癌症发病率的上升、从医院到门诊护理机构的转变以及癌症患者越来越多地接受肠内餵养配方作为肠外营养的有效替代品，可能会推动肿瘤学应用中对肠内餵养配方的需求。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球肠内餵养配方奶粉市场的各个细分市场进行了包容性评估。肠内餵养配方奶粉行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肠内餵养配方奶粉市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肠内餵养配方奶粉市场的主要参与者包括雅培、达能、费森尤斯卡比、雀巢、Victus, Inc.、Primus Pharmaceuticals, Inc.、明治控股。有限公司和 Rickett Benckiser Group Plc。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：肠内餵养配方 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按流量类型分類的市场吸引力分析
    • 分阶段市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 按销售渠道分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球肠内餵养配方奶粉市场分析：按产品分类

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 标准配方
  • 特定疾病配方

第 7 章：全球肠内餵养配方市场分析：按流程类型

  • 按流程类型概述
  • 历史和预测数据
  • 按流量类型分析
  • 间歇式餵料流程
  • 连续进料流量

第 8 章：全球肠内餵养配方奶粉市场分析：按阶段

  • 阶段概览
  • 历史和预测数据
  • 阶段分析
  • 成人
  • 儿科

第 9 章：全球肠内餵养配方奶粉市场分析：按适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按指标分析
  • 老年痴呆症
  • 营养缺乏
  • 癌症护理
  • 糖尿病
  • 慢性肾脏病
  • 孤儿病
  • 吞嚥困难
  • 疼痛管理
  • 吸收不良/胃肠道疾病/腹泻
  • 其他的

第 10 章：全球肠内餵养配方奶粉市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院（心脏病科、神经科、重症监护 (ICU)、肿瘤科、其他）
  • 家庭护理

第 11 章：全球肠内餵养配方奶粉市场分析：按销售渠道

  • 销售渠道概览
  • 历史和预测数据
  • 按销售渠道分析
  • 网上销售
  • 机构销售
  • 零售销售

第 12 章：全球肠内餵养配方奶粉市场销售分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 13 章：肠内餵养配方奶粉公司的竞争格局

  • 肠内餵养配方奶粉市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 14 章：公司简介

  • 顶级公司股票分析
  • 市场集中度
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danone SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Fresenius Kabi
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nestle
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Victus Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Primus Pharmaceuticals Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Meiji Holdings. Co. Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Rickett Benckiser Group Plc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219148

The global demand for Enteral Feeding Formulas Market is presumed to reach the market size of nearly USD 18.79 BN by 2030 from USD 9.62 BN in 2022 with a CAGR of 7.72% under the study period 2023 - 2030.

Enteral feeding formulas are also known as tube feeding formula considered for medical ailments such as cancer, eating inability, chronic illness, life-threatening injuries, and stroke or attacks. The term enteral feeding describes a procedure in which food is intake through the gastrointestinal tract. The stomach, esophagus, intestines, and mouth constitute the gastrointestinal tract. The nutrition taken via a tube goes directly to the stomach & small intestine. This form of feeding method is used as a supplement. This feeding method enables patients to receive the nutrition that keeps their gastrointestinal tract active.

MARKET DYNAMICS:

The robust growth of the enteral feeding formula market is driven by the increasing prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments and other chronic diseases. The rise in preterm births is another major factor augmenting the market growth. The demand for enteral feeding formulas in oncological applications is likely to be fueled by the rising incidence of cancer, the transition from hospitals to outpatient care settings, and the growing acceptance of enteral feeding formulas as an efficient substitute for parenteral nutrition among cancer patients.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of enteral feeding formulas. The growth and trends of enteral feeding formulas industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the enteral feeding formulas market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Standard Formula
  • Disease-Specific Formula

By Flow Type

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

By Stage

  • Adult
  • Pediatric

By Indication

  • Alzheimer'S
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By End-User

  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others)
  • Home Care

By Sales Channel

  • Online Sales
  • Institutional Sales
  • Retail Sales

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Enteral Feeding Formulas market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enteral feeding formulas market include Abbott, Danone SA, Fresenius Kabi, Nestle, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd and Rickett Benckiser Group Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ENTERAL FEEDING FORMULAS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Flow Type
    • 3.7.3 Market Attractiveness Analysis By Stage
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By End-user
    • 3.7.6 Market Attractiveness Analysis By Sales Channel
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Standard Formula Historic and Forecast Sales by Regions
  • 6.5 Disease-specific Formula Historic and Forecast Sales by Regions

7 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY FLOW TYPE

  • 7.1 Overview by Flow Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Flow Type
  • 7.4 Intermittent Feeding Flow Historic and Forecast Sales by Regions
  • 7.5 Continuous Feeding Flow Historic and Forecast Sales by Regions

8 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY STAGE

  • 8.1 Overview by Stage
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Stage
  • 8.4 Adult Historic and Forecast Sales by Regions
  • 8.5 Pediatric Historic and Forecast Sales by Regions

9 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Alzheimer's Historic and Forecast Sales by Regions
  • 9.5 Nutrition Deficiency Historic and Forecast Sales by Regions
  • 9.6 Cancer Care Historic and Forecast Sales by Regions
  • 9.7 Diabetes Historic and Forecast Sales by Regions
  • 9.8 Chronic Kidney Diseases Historic and Forecast Sales by Regions
  • 9.9 Orphan Diseases Historic and Forecast Sales by Regions
  • 9.10. Dysphagia Historic and Forecast Sales by Regions
  • 9.11 Pain Management Historic and Forecast Sales by Regions
  • 9.12 Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales by Regions
  • 9.13 Others Historic and Forecast Sales by Regions

10 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY END-USER

  • 10.1 Overview by End-user
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-user
  • 10.4 Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Historic and Forecast Sales by Regions
  • 10.5 Home Care Historic and Forecast Sales by Regions

11 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY SALES CHANNEL

  • 11.1 Overview by Sales Channel
  • 11.2 Historical and Forecast Data
  • 11.3 Analysis by Sales Channel
  • 11.4 Online Sales Historic and Forecast Sales by Regions
  • 11.5 Institutional Sales Historic and Forecast Sales by Regions
  • 11.6 Retail Sales Historic and Forecast Sales by Regions

12 . GLOBAL ENTERAL FEEDING FORMULAS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1. Overview, Historic and Forecast Sales Analysis
    • 12.3.2. North America By Segment Sales Analysis
    • 12.3.3. North America By Country Sales Analysis
    • 12.3.4. United State Sales Analysis
    • 12.3.5. Canada Sales Analysis
    • 12.3.6. Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1. Overview, Historic and Forecast Sales Analysis
    • 12.4.2. Europe by Segment Sales Analysis
    • 12.4.3. Europe by Country Sales Analysis
    • 12.4.4. United Kingdom Sales Analysis
    • 12.4.5. France Sales Analysis
    • 12.4.6. Germany Sales Analysis
    • 12.4.7. Italy Sales Analysis
    • 12.4.8. Russia Sales Analysis
    • 12.4.9. Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1. Overview, Historic and Forecast Sales Analysis
    • 12.5.2. Asia Pacific by Segment Sales Analysis
    • 12.5.3. Asia Pacific by Country Sales Analysis
    • 12.5.4. China Sales Analysis
    • 12.5.5. India Sales Analysis
    • 12.5.6. Japan Sales Analysis
    • 12.5.7. South Korea Sales Analysis
    • 12.5.8. Australia Sales Analysis
    • 12.5.9. Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1. Overview, Historic and Forecast Sales Analysis
    • 12.6.2. Latin America by Segment Sales Analysis
    • 12.6.3. Latin America by Country Sales Analysis
    • 12.6.4. Brazil Sales Analysis
    • 12.6.5. Argentina Sales Analysis
    • 12.6.6. Peru Sales Analysis
    • 12.6.7. Chile Sales Analysis
    • 12.6.8. Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1. Overview, Historic and Forecast Sales Analysis
    • 12.7.2. Middle East & Africa by Segment Sales Analysis
    • 12.7.3. Middle East & Africa by Country Sales Analysis
    • 12.7.4. Saudi Arabia Sales Analysis
    • 12.7.5. UAE Sales Analysis
    • 12.7.6. Israel Sales Analysis
    • 12.7.7. South Africa Sales Analysis
    • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE ENTERAL FEEDING FORMULAS COMPANIES

  • 13.1. Enteral Feeding Formulas Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14 . COMPANY PROFILES OF ENTERAL FEEDING FORMULAS INDUSTRY

  • 14.1. Top Company Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Abbott
    • 14.3.1. Company Overview
    • 14.3.2. Company Revenue
    • 14.3.3. Products
    • 14.3.4. Recent Developments
  • 14.4. Danone SA
    • 14.4.1. Company Overview
    • 14.4.2. Company Revenue
    • 14.4.3. Products
    • 14.4.4. Recent Developments
  • 14.5. Fresenius Kabi
    • 14.5.1. Company Overview
    • 14.5.2. Company Revenue
    • 14.5.3. Products
    • 14.5.4. Recent Developments
  • 14.6. Nestle
    • 14.6.1. Company Overview
    • 14.6.2. Company Revenue
    • 14.6.3. Products
    • 14.6.4. Recent Developments
  • 14.7. Victus Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Company Revenue
    • 14.7.3. Products
    • 14.7.4. Recent Developments
  • 14.8. Primus Pharmaceuticals Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Company Revenue
    • 14.8.3. Products
    • 14.8.4. Recent Developments
  • 14.9. Meiji Holdings. Co. Ltd
    • 14.9.1. Company Overview
    • 14.9.2. Company Revenue
    • 14.9.3. Products
    • 14.9.4. Recent Developments
  • 14.10. Rickett Benckiser Group Plc.
    • 14.10.1. Company Overview
    • 14.10.2. Company Revenue
    • 14.10.3. Products
    • 14.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Standard Formula Market Sales by Geography (USD MN)
  • Disease-specific Formula Market Sales by Geography (USD MN)
  • Analysis Market by Flow Type (USD MN)
  • Intermittent Feeding Flow Market Sales by Geography (USD MN)
  • Continuous Feeding Flow Market Sales by Geography (USD MN)
  • Analysis by Stage (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
  • Home Care Market Sales by Geography (USD MN)
  • Analysis by Sales Channel (USD MN)
  • Online Sales Market Sales by Geography (USD MN)
  • Institutional Sales Market Sales by Geography (USD MN)
  • Retail Sales Market Sales by Geography (USD MN)
  • Global Enteral Feeding Formulas Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Enteral Feeding Formulas Report
  • Market Research Process
  • Market Research Methodology
  • Global Enteral Feeding Formulas Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Flow Type
  • Market Attractiveness Analysis by Stage
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Sales Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Standard Formula Market Sales by Geography (USD MN)
  • Disease-specific Formula Market Sales by Geography (USD MN)
  • Global Market Analysis by Flow Type (USD MN)
  • Intermittent Feeding Flow Market Sales by Geography (USD MN)
  • Continuous Feeding Flow Market Sales by Geography (USD MN)
  • Global Market Analysis by Stage (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Pediatric Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Alzheimer's Market Sales by Geography (USD MN)
  • Nutrition Deficiency Market Sales by Geography (USD MN)
  • Cancer Care Market Sales by Geography (USD MN)
  • Diabetes Market Sales by Geography (USD MN)
  • Chronic Kidney Diseases Market Sales by Geography (USD MN)
  • Orphan Diseases Market Sales by Geography (USD MN)
  • Dysphagia Market Sales by Geography (USD MN)
  • Pain Management Market Sales by Geography (USD MN)
  • Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
  • Home Care Market Sales by Geography (USD MN)
  • Global Market Analysis by Sales Channel (USD MN)
  • Online Sales Market Sales by Geography (USD MN)
  • Institutional Sales Market Sales by Geography (USD MN)
  • Retail Sales Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.